A novel type I interferon antagonist has in vivo efficacy in a model of SIV infection in rhesus macaques

Netanya G. Sandler, Richard T. Zhu, Jacob D. Estes, Eli Boritz, Srinivas Rao, Jeffrey D. Lifson, Doron Levin, Gideon Schreiber, Jerome A. Langer, Daniel C. Douek

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Keywords: Biochemistry & Molecular Biology; Cell Biology; Immunology
Original languageEnglish
Pages (from-to)296-296
Number of pages1
JournalCytokine
Volume63
Issue number3
DOIs
StatePublished - Sep 2013
EventAnnual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research - San Francisco, CA
Duration: 29 Sep 201329 Sep 2013

Fingerprint

Dive into the research topics of 'A novel type I interferon antagonist has in vivo efficacy in a model of SIV infection in rhesus macaques'. Together they form a unique fingerprint.

Cite this